WallStreetZenWallStreetZen

NASDAQ: BBLG
Bone Biologics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BBLG earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.9M
Current Profit Margin
0%

BBLG Return on Equity

Current Company
-236%
Current Industry
10.5%
Current Market
188%
BBLG's Return on Equity (-236%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BBLG announces earnings.

BBLG Return on Assets

Current Company
-154.8%
Current Industry
5.3%
BBLG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BBLG Return on Capital Employed

Current Company
-307.9%
Current Industry
8.3%
BBLG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BBLG vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BBLG$0.00-$8.95M-$8.95MN/AN/A
SINT$2.63M-$6.60M-$8.29M+94.24%N/A
BJDX$0.00-$9.17M-$9.95M-100.00%N/A
TIVC$1.18M-$8.06M-$8.24M+29.36%N/A
NUWE$8.86M-$16.36M-$22.63M+12.14%N/A
View Top Medical Device Stocks

BBLG earnings dates

Next earnings date
May 6, 2024

Bone Biologics Earnings & Revenue FAQ

What were BBLG's earnings last quarter?

On Invalid Date, Bone Biologics (NASDAQ: BBLG) reported Q4 2023 earnings per share (EPS) of $3.39, up 85.82% year over year. Total Bone Biologics earnings for the quarter were -$1.55 million. In the same quarter last year, Bone Biologics's earnings per share (EPS) was $23.91.

If you're new to stock investing, here's how to buy Bone Biologics stock.

What was BBLG's earnings growth in the past year?

As of Q2 2024, Bone Biologics's earnings has grown year over year. Bone Biologics's earnings in the past year totalled -$8.95 million.

What is BBLG's earnings date?

Bone Biologics's earnings date is Invalid Date. Add BBLG to your watchlist to be reminded of BBLG's next earnings announcement.

What was BBLG's revenue last quarter?

On Invalid Date, Bone Biologics (NASDAQ: BBLG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Bone Biologics's revenue was $0.00.

What was BBLG's revenue growth in the past year?

As of Q2 2024, Bone Biologics's revenue has grown null year over year. Bone Biologics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.